Total planned funding: $344,061,163
Allocations
Countries/Regions
Eswatini | $344,061,163 |
Organizational Types
Private Contractor | $80,480,884 |
Unknown | $74,710,865 |
University | $60,421,828 |
NGO | $55,306,587 |
Own Agency | $43,739,700 |
Host Country Government Agency | $11,202,398 |
FBO | $10,806,488 |
Other USG Agency | $3,915,689 |
Multi-lateral Agency | $2,836,724 |
Implementing Agency | $640,000 |
Program Areas
Care | $98,428,940 |
Treatment | $83,532,770 |
Prevention | $65,580,022 |
Governance and Systems | $44,178,611 |
Management and Operations | $27,097,257 |
Testing | $25,243,563 |
Budget Codes
HTXS: Treatment: Adult Treatment | $69,681,204 |
HBHC: Care: Adult Care and Support | $37,392,759 |
HKID: Care: Orphans and Vulnerable Children | $33,702,104 |
HVMS: Management and Operations | $27,097,257 |
HVCT: Testing: HIV Testing and Counseling | $25,243,563 |
HVOP: Sexual Prevention: Other Sexual Prevention | $22,537,455 |
HVSI: Strategic Information | $22,127,074 |
HVTB: Care: TB/HIV | $19,550,628 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $19,193,074 |
OHSS: Health Systems Strengthening | $15,599,181 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $11,485,693 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $11,391,800 |
PDTX: Treatment: Pediatric Treatment | $8,464,282 |
PDCS: Care: Pediatric Care and Support | $7,783,449 |
HLAB: Laboratory Infrastructure | $6,452,356 |
HTXD: Treatment: ARV Drugs | $5,387,284 |
HMBL: Biomedical Prevention: Blood Safety | $972,000 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Not Available:
$56,250,999
Countries/Regions
Columbia University:
$49,138,452
Countries/Regions
Pact, Inc.:
$39,738,750
Countries/Regions
Chemonics International:
$16,579,695
Countries/Regions